107 related articles for article (PubMed ID: 12419020)
1. Pharmacokinetic scaling of bisphenol A by species-invariant time methods.
Cho CY; Shin BS; Jung JH; Kim DH; Lee KC; Han SY; Kim HS; Lee BM; Yoo SD
Xenobiotica; 2002 Oct; 32(10):925-34. PubMed ID: 12419020
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic scaling of SJ-8029, a novel anticancer agent possessing microtubule and topoisomerase inhibiting activities, by species-invariant time methods.
Shin BS; Kim DH; Cho CY; Park SK; Chung SG; Cho EH; Lee SH; Joo JH; Kwon HS; Lee KC; Yoo SD
Biopharm Drug Dispos; 2003 Jul; 24(5):191-7. PubMed ID: 12784318
[TBL] [Abstract][Full Text] [Related]
3. Interspecies scaling of oleanolic acid in mice, rats, rabbits and dogs and prediction of human pharmacokinetics.
Ji HY; Shin BS; Jeong DW; Park EJ; Park ES; Yoo SD; Lee HS
Arch Pharm Res; 2009 Feb; 32(2):251-7. PubMed ID: 19280156
[TBL] [Abstract][Full Text] [Related]
4. Prediction of clinical pharmacokinetic parameters of linezolid using animal data by allometric scaling: applicability for the development of novel oxazolidinones.
Bhamidipati RK; Dravid PV; Mullangi R; Srinivas NR
Xenobiotica; 2004 Jun; 34(6):571-9. PubMed ID: 15277016
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of liquiritigenin in mice, rats, rabbits, and dogs, and animal scale-up.
Kang HE; Jung HY; Cho YK; Kim SH; Sohn SI; Baek SR; Lee MG
J Pharm Sci; 2009 Nov; 98(11):4327-42. PubMed ID: 19226634
[TBL] [Abstract][Full Text] [Related]
6. Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Shim HJ; Kim YC; Lee JH; Kwon JW; Kim WB; Kim YG; Kim SH; Lee MG
Biopharm Drug Dispos; 2005 Oct; 26(7):269-77. PubMed ID: 15991256
[TBL] [Abstract][Full Text] [Related]
7. Interspecies scaling of a camptothecin analogue: human predictions for intravenous topotecan using animal data.
Ahlawat P; Srinivas NR
Xenobiotica; 2008 Nov; 38(11):1377-85. PubMed ID: 18946781
[TBL] [Abstract][Full Text] [Related]
8. Allometric scaling for predicting human clearance of bisphenol A.
Collet SH; Picard-Hagen N; Lacroix MZ; Puel S; Viguié C; Bousquet-Melou A; Toutain PL; Gayrard V
Toxicol Appl Pharmacol; 2015 May; 284(3):323-9. PubMed ID: 25759244
[TBL] [Abstract][Full Text] [Related]
9. Interspecies scaling of interferon disposition and comparison of allometric scaling with concentration-time transformations.
Lave T; Levet-Trafit B; Schmitt-Hoffmann AH; Morgenroth B; Richter W; Chou RC
J Pharm Sci; 1995 Nov; 84(11):1285-90. PubMed ID: 8587044
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Human Pharmacokinetics of Ulixertinib, a Novel ERK1/2 Inhibitor from Mice, Rats, and Dogs Pharmacokinetics.
Suresh PS; Jairam RK; Chandrasekhar DV; Vinod AB; Hiremath RA; Raj A; Zainuddin M; Bhamidipati RK; Mullangi R
Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):453-460. PubMed ID: 29470718
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic and toxicity scaling of the antitumor agents amsacrine and CI-921, a new analogue, in mice, rats, rabbits, dogs, and humans.
Paxton JW; Kim SN; Whitfield LR
Cancer Res; 1990 May; 50(9):2692-7. PubMed ID: 2328494
[TBL] [Abstract][Full Text] [Related]
12. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
[TBL] [Abstract][Full Text] [Related]
13. Interspecies pharmacokinetic scaling of a new carbapenem, DA-1131, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
Kim SH; Kim WB; Lee MG
Biopharm Drug Dispos; 1998 May; 19(4):231-5. PubMed ID: 9604122
[TBL] [Abstract][Full Text] [Related]
14. Elucidation of human amphotericin B pharmacokinetics: identification of a new potential factor affecting interspecies pharmacokinetic scaling.
Robbie G; Chiou WL
Pharm Res; 1998 Oct; 15(10):1630-6. PubMed ID: 9794508
[TBL] [Abstract][Full Text] [Related]
15. Interspecies pharmacokinetic comparisons and allometric scaling of napsagatran, a low molecular weight thrombin inhibitor.
Lavé T; Portmann R; Schenker G; Gianni A; Guenzi A; Girometta MA; Schmitt M
J Pharm Pharmacol; 1999 Jan; 51(1):85-91. PubMed ID: 10197423
[TBL] [Abstract][Full Text] [Related]
16. Physiologically based pharmacokinetics of bisphenol A.
Shin BS; Kim CH; Jun YS; Kim DH; Lee BM; Yoon CH; Park EH; Lee KC; Han SY; Park KL; Kim HS; Yoo SD
J Toxicol Environ Health A; 2004 Dec; 67(23-24):1971-85. PubMed ID: 15513896
[TBL] [Abstract][Full Text] [Related]
17. Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin.
Jolling K; Perez Ruixo JJ; Hemeryck A; Vermeulen A; Greway T
Eur J Pharm Sci; 2005 Apr; 24(5):465-75. PubMed ID: 15784336
[TBL] [Abstract][Full Text] [Related]
18. Prediction of the pharmacokinetic parameters of reduced-dolasetron in man using in vitro-in vivo and interspecies allometric scaling.
Sanwald-Ducray P; Dow J
Xenobiotica; 1997 Feb; 27(2):189-201. PubMed ID: 9058532
[TBL] [Abstract][Full Text] [Related]
19. Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
Deguchi T; Watanabe N; Kurihara A; Igeta K; Ikenaga H; Fusegawa K; Suzuki N; Murata S; Hirouchi M; Furuta Y; Iwasaki M; Okazaki O; Izumi T
Drug Metab Dispos; 2011 May; 39(5):820-9. PubMed ID: 21282406
[TBL] [Abstract][Full Text] [Related]
20. Preclinical pharmacokinetics and interspecies scaling of ragaglitazar, a novel biliary excreted PPAR dual activator.
Pavankuamr VV; Vinu CA; Mullangi R; Srinivas NR
Eur J Drug Metab Pharmacokinet; 2007; 32(1):29-37. PubMed ID: 17479541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
